TXN
Thioredoxin
Also known as: THIO_HUMAN, TRX, Trx80
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10599
- Gene
- TXN
- Ensembl
- ENSG00000136810
- Chromosome
- 9
- Canonical length
- 105 aa
- Protein class
- Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene acts as a homodimer and is involved in many redox reactions. The encoded protein is active in the reversible S-nitrosylation of cysteines in certain proteins, which is part of the response to intracellular nitric oxide. This protein is found in the cytoplasm. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
105 residues, UniProt reviewed canonical sequence.
>P10599|TXN
1 MVKQIESKTA FQEALDAAGD KLVVVDFSAT WCGPCKMIKP FFHSLSEKYS NVIFLEVDVD
61 DCQDVASECE VKCMPTFQFF KKGQKVGEFS GANKEKLEAT INELVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TXN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 1,238 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 1,238 nTPM
- salivary gland: 434 nTPM
- colon: 426 nTPM
- rectum: 408 nTPM
- liver: 407 nTPM
- kidney: 401 nTPM
Single-cell type
- esophageal suprabasal cells: 15,116 nCPM
- esophageal apical cells: 9,041 nCPM
- gastric progenitor cells: 5,419 nCPM
- esophageal basal cells: 4,687 nCPM
- suprabasal keratinocytes: 3,557 nCPM
- respiratory secretory cells: 2,635 nCPM
Immune cell
- plasmacytoid DC: 1,646 nTPM
- eosinophil: 1,360 nTPM
- neutrophil: 1,219 nTPM
- basophil: 487 nTPM
- myeloid DC: 477 nTPM
- T-reg: 338 nTPM
Brain region
- white matter: 94 nTPM
- medulla oblongata: 93 nTPM
- pons: 90 nTPM
- hypothalamus: 88 nTPM
- cerebral cortex: 81 nTPM
- spinal cord: 80 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0.2
- gnomAD missense Z
- 1.14
- DepMap mean gene effect
- -1.07
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell redox homeostasis
- cellular detoxification of hydrogen peroxide
- negative regulation of protein export from nucleus
- negative regulation of transcription by RNA polymerase II
- positive regulation of DNA binding
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- response to nitric oxide
- response to radiation
Molecular functions
- protein homodimerization activity
- protein-disulfide reductase [NAD(P)H] activity
- protein-disulfide reductase activity
- RNA binding
- thioredoxin-disulfide reductase (NADPH) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TXN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TXN as an antibody target. Whether an autoantibody or antibody against TXN could matter depends on whether native TXN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TXN is annotated as secreted, so native TXN circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label TXN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...